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Background: Vitamin D deficiencies and increases in urinary albumin excretion (UAE) are both important and
potentially related health problems; however, the nature of their relationship has not been established in
normoalbuminuric subjects.
Methods: We obtained data from 14,594 normoalbuminuric Korean adults who underwent voluntary health
screenings. We used a generalized additive model to examine the threshold level for relationship between serum
25-hydroxyvitamin D [25(OH)D] and urinary-albumin creatinine ratio (UACR) levels. We conducted multivariate
logistic regression for high-normal UAE (UACR, 10–29 mg/g), according to various categories of vitamin D status.
Results: The generalized additive model confirmed a non-linear relationship between serum 25(OH)D and UACR
levels, and the threshold concentration of 25(OH)D was 8.0 ng/mL after multivariate adjustment. Comparing
subjects who fell into the lowest category of serum 25(OH)D levels with subjects who were in the reference range
(the highest category), we observed that the multivariate adjusted odds ratio (OR) for high-normal UAE was
significantly increased, regardless of the criteria used to categorize vitamin D levels: OR of the 1st quartile over the 4th
quartile, 1.20 (95% CI, 1.04-1.39); OR of the 1.0-4.9th percentile over the 50-100th percentile, 1.56 (95% CI, 1.25-1.93); and
OR of vitamin D deficiency group over vitamin D sufficiency group, 1.28 (95% CI, 1.08-1.52).
Conclusions: We demonstrated that there was an inverse relationship between serum 25(OH)D less than 8.0 ng/mL
and UACR in normoalbuminuric subjects, suggesting that severe vitamin D deficiency could cause an increase in UAE
in subjects with normoalbuminuria.
Keywords: Epidemiology, Low-grade albuminuria, Threshold, Vitamin D deficiencyBackground
Albuminuria is not only an independent prognostic
marker for kidney disease, but it is also an established
predictor of cardiovascular disease and all-cause mortal-
ity [1-3]. However, there has been considerable debate
over the threshold level of urinary albumin excretion
(UAE) that predicts adverse clinical outcomes. Recently,
meta-analyses of general- and high-risk population cohorts* Correspondence: dkkim73@gmail.com
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unless otherwise stated.have demonstrated that increased UAE, even within the
normoalbuminuric range, especially a urinary albumin-
creatinine ratio (UACR) of 10–29 mg/g, is an independ-
ent predictor of cardiovascular disease and all-cause
mortality [4,5]. These noteworthy reports on the prognos-
tic significance of the higher range of normoalbuminuria
have challenged the previous definition of normoalbumi-
nuria. Furthermore, given the high prevalence of the
greater range of normoalbuminuria in the general popula-
tion [6], we believe that exploring its risk factors might
have important public health and clinical implications.
Vitamin D deficiency is an important public health
issue because of its association with numerous adverse. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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minuria has been suggested; however, most of these
studies have been limited to subjects with chronic kid-
ney disease or diabetes, which are susceptible to albu-
minuria [8-12]. Recently, general population studies
have shown that vitamin D deficiency was associated with
prevalent microalbuminuria and that vitamin D deficiency
posed an increased risk of de novo microalbuminuria
[13,14]. However, these studies did not consider high-
normal UAE as a separate outcome variable, despite its
obvious clinical significance and high prevalence. More-
over, previous studies did not consider a possible non-
linear relationship between 25-hydroxyvitamin D [25
(OH)D] and UACR levels, although recent large-scale
studies have suggested a non-linear relationship be-
tween the risks of various clinical conditions and serum
25(OH)D levels [15-20].
Based on previous findings regarding the association
between vitamin D and albuminuria, we postulated that
low vitamin D levels might be a potential risk factor for
high-normal UAE. In the present study, we examined
the relationship between serum 25(OH)D and UACR
levels in a large number of subjects who underwent
voluntary health screenings. We aimed to estimate the
threshold level of serum 25(OH)D less than which UAE
would begin to increase.
Methods
Study population
We conducted this study using data from subjects who
underwent voluntary health screenings at three university-
affiliated hospitals, including Seoul National University
Hospital (Seoul, Korea), Samsung Medical Center (Seoul,
Korea), and Asan Medical Center (Seoul, Korea), between
January 2008 and March 2012. Initially, we recruited a
total of 16,870 subjects, who were aged ≥20 years old, and
they underwent measurements of serum 25(OH)D and
UACR. From that group, we excluded 2,276 subjects with
outlying values of serum 25(OH)D (>125 ng/mL, N = 3)
or UACR ≥30 mg/g (N = 2,276). A total of 14,594 partici-
pants were included in the study analysis. This study was
approved by the institutional review boards of the three
hospitals and performed in accordance with the principle
of Helsinki Declaration. The IRBs approved waiver of
the requirement for obtaining written informed consent
because this study was conducted by retrospective chart
review and presented no more than minimal risk to
participants.
Normalization of laboratory tests
The quantile normalization method [21,22] was applied
to combine the laboratory test results of the three par-
ticipating institutions, using a Java programming tool
(Eclipse, version 3.7.1, IBM, Riverton, NJ). The quantilenormalization method is a technique that redistributes
values of datasets to have same statistical properties.
The quantile normalization makes datasets have identi-
cal distribution by averaging values at the same ranking
in each dataset. Each datum of a distribution was sorted
in ascending order, and the data in the same rank were
averaged together. The averaged value was set as the new
normalized value. To determine the reference range, all of
the laboratory test results were subdivided by reference
range, and subsequently, each stratum was independently
normalized.
Vitamin D and albuminuria
We measured serum 25(OH)D levels at a single baseline
visit. Serum 25(OH)D levels were measured using a
radioimmunoassay kit (BIOSOURCE, Brussels, Belgium)
and a gamma-counter (COBRA 5010 Series Quantum,
PACKARD, Meriden, CT) at two medical centers (Seoul
National University Hospital and Asan Medical Center),
while at Samsung Medical Center, these levels were
measured by liquid chromatography-tandem mass spec-
trometry assay, using a mass spectrometer (6460 Triple
Quadrupole mass spectrometer, Agilent, Santa Clara,
CA). We categorized serum 25(OH)D levels by quar-
tiles. We also divided the subjects into four groups by
percentile categories of 25(OH)D concentrations (1.0-
4.9th; 5.0-24.9th, 25.0-49.9th and 50.0-100.0th percentile).
Additionally, we assigned categories of serum 25(OH)D
levels according to generally used clinical cut-off points
(vitamin D deficiency, <15.0 ng/mL; insufficiency, 15.0-
29.9 ng/mL; sufficiency, >30 ng/mL) [23,24]. For an
assessment for UACR, urine albumin and creatinine
were measured from a single random voided urine sample.
Urine albumin levels were measured by immunoturbi-
metric assay (ALBT2, Roche, Basel, Switzerland). Urine
creatinine levels were measured using the Jaffe method
(CREJ2, Roche). We classified the status of UAE into two
groups according to UACR levels. Normal UAE was de-
fined as UACR <10 mg/g and high-normal UAE was de-
fined as UACR 10–29 mg/g.
Study variables
Demographic and clinical data included age, sex, body
mass index (BMI), blood pressure, blood and urine chem-
istry analysis, and medication history, including vitamin D
supplements and renin angiotensin system (RAS) blockers.
We classified time points into four seasons as follows;
spring (March to May); summer (June to August); autumn
(September to November); and winter (December to
February). Additionally, we assembled information about
medical co-morbidities. Hypertension was defined as
blood pressure ≥140/90 mmHg; a reported history of
hypertension or those individuals who received antihy-
pertensive medications were documented. Diabetes was
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viduals who received oral hypoglycemic agents or insu-
lin. The estimated glomerular filtration rate (eGFR) was
calculated using four-variable Modification of Diet in
Renal Disease equation [25].
Statistical analysis
All of the analyses and calculations were performed
using SPSS Statistics software (version 19.0, Chicago, IL)
and R software, version 2.15.1, with the mgcv package
(The Comprehensive R Archive Network: http://cran.r-
project.org). Continuous variables with normal distribu-
tions are presented as the means ± SDs and were compared
using Student’s t-test. Non-normally distributed con-
tinuous variables are expressed as the medians (25-75%
interquartile ranges) and were compared using the
Mann–Whitney U-test. Categorical variables are expressed
as frequencies or percentages, and comparison between
groups was performed using the chi-squared test for
dichotomized variables. We conducted logistic regres-
sion analysis to identify the independent effects of
serum 25(OH)D levels on the risk of high-normal UAE.
Two-sided P values were reported, and statistical sig-
nificance was defined as P < 0.05.
A Gaussian model was adapted to evaluate the effects
of serum 25(OH)D levels on UACR levels. To investigate
the continuous relationship between serum 25(OH)D
and UACR levels, we used generalized additive models
(GAMs) with a smoothing function for UACR levels
[26]. In addition to univariate analysis, we performed
multivariate analysis, constructing multiple models ad-
justed for relevant covariates in a stepwise manner. To
estimate the threshold of the serum 25(OH)D concen-
tration for each model, we first selected the serum 25
(OH)D range and fitted the GAM to quantify the rela-
tionship between serum 25(OH)D and UACR levels.
Akaike’s information criterion (AIC) was used to deter-
mine a primary measurement of model fit; a lower valueFigure 1 Distribution of serum 25-hydroxyvitamin D levels (A) and urof AIC indicated a better model fit. The threshold of
serum 25(OH)D was chosen, based on the best fit deter-
mined by AIC among the models, with threshold values
that differed in 0.2-increments. We plotted the optimal
criterion on the GAM model. Predicted probability was
calculated from the multivariate logistic regression model.
We presented curves of predicted probability and 95% CIs
using the lowess regression.
Results
Clinical characteristics
A total of 14,594 subjects were included in this study.
The mean age was 54 years old, and 64.7% of parti-
cipants were male. The seasonal distribution of the
examination was nearly even across the entire examin-
ation period. The serum 25(OH)D levels were normally
distributed (Figure 1A). However, UACR showed a highly
skewed distribution (Figure 1B). Table 1 presents the clin-
ical characteristics of study population. The mean serum
25(OH)D and eGFR levels were 20.4 ± 8.4 ng/mL and
85.8 mL/min/1.73 m2, respectively, and the median value
of UACR was 4.3 mg/g. Overall, 28.0% of participants
had vitamin D deficiency. The serum 25(OH)D level
was lower in high-normal UAE than in normal UAE.
The hemoglobin level was also lower in high-normal
UAE compared to normal UAE; however, the serum
albumin and eGFR levels were not significantly different
between the groups. Additionally, the prevalence of dia-
betes and hypertension in subjects with high-normal
UAE was significantly higher compared to those with
normal UAE.
Associations of serum 25(OH)D levels with UACR and
threshold 25(OH)D values for their associations with
albuminuria
We explored the continuous relationship between serum
25(OH)D and UACR levels. As shown in the lowess line
of Figure 2, there was no specific association of seruminary albumin-creatinine ratios (B).










(N = 14,594) (N = 12,170) (N = 2,424) (N = 10,505) (N = 4,089)
Age (years) 54.0 ± 9.0 53.4 ± 8.5 56.6 ± 9.8 <0.01 54.3 ± 8.7 53.0 ± 9.0 <0.01
Male (N/%) 9,441/64.7 8,168/67.1 1,276/52.5 <0.01 7,237/68.9 2,204/53.9 <0.01
Season (N/%) <0.01 <0.01
Spring 3,813/26.1 3,195/26.3 619/25.5 2,550/24.3 1,263/30.9
Summer 3,772/25.8 3,217/26.4 557/22.9 3,004/28.6 768/18.8
Autumn 3,620/24.8 3,010/24.7 611/25.2 2,853/27.2 767/18.8
Winter 3,389/23.2 2,748/22.6 642/26.4 2,098/20.0 1,291/31.6
BMI 24.39 ± 2.97 24.36 ± 2.90 24.53 ± 3.25 0.15 24.54 ± 2.90 24.01 ± 3.12 <0.01
25(OH)D (ng/mL) 20.4 ± 8.4 20.5 ± 8.4 20.0 ± 8.7 <0.01 23.8 ± 7.4 11.7 ± 2.3 <0.01
UACR (mg/g) 4.3 (2.5-7.7) 3.6 (2.2-5.6) 14.5 (11.9-19.1) <0.01 4.2 (2.4-7.5) 4.6 (2.7-8.2) <0.01
Hemoglobin (g/dL) 14.5 ± 1.5 14.5 ± 1.5 14.2 ± 1.7 <0.01 14.6 ± 1.5 14.2 ± 1.6 <0.01
Serum albumin (g/dL) 4.4 ± 0.3 4.4 ± 0.3 4.4 ± 0.3 0.89 4.4 ± 0.3 4.4 ± 0.3 <0.01
Serum calcium (mg/dL) 9.1 ± 0.4 9.0 ± 0.4 9.1 ± 0.4 <0.01 9.1 ± 0.4 9.0 ± 0.4 <0.01
Serum phosphorus (mg/dL) 3.5 ± 0.5 3.4 ± 0.5 3.5 ± 0.6 <0.01 3.4 ± 0.5 3.5 ± 0.5 <0.01
hs-CRP (mg/dL) 0.10 (0.00-0.10) 0.10 (0.00-0.10) 0.10 (0.00-0.20) <0.01 0.10 (0.00-0.10) 0.10 (0.00-0.10) 0.003
Total cholesterol 189 ± 35 189 ± 34 188 ± 39 0.38 190 ± 35 187 ± 36 <0.01
LDL-cholesterol 121 ± 33 122 ± 32 120 ± 35 0.153 122 ± 33 120 ± 33 <0.01
HDL-cholesterol 54 ± 13 54 ± 13 54 ± 14 0.762 54 ± 13 54 ± 13 0.768
Triglyceride 120 ± 74 119 ± 72 126 ± 82 <0.01 122 ± 74 116 ± 74 <0.01
eGFR (mL/min/1.73 m2) 85.8 ± 18.6 86.3 ± 17.3 86.7 ± 20.7 0.365 85.1 ± 17.4 89.4 ± 18.7 <0.01
Diabetes 1,348/9.2 1,001/8.2 348/14.3 <0.01 972/9.3 376/9.2 0.914
Hypertension 1,721/11.8 1,289/10.6 435/17.9 <0.01 1,279/12.2 442/10.8 0.022
RAS blocker 1,013/6.9 765/6.3 250/10.3 <0.01 755/7.2 258/6.3 0.061
Vitamin D supplementation 1,012/6.9 766/6.8 247/11.0 <0.01 700/7.2 312/8.3 0.038
Abbreviations: 25(OH)D 25-hydroxyvitamin D, BMI body mass index, UACR urine albumin-creatinine ratio, hs-CRP high sensitivity-C-reactive protein, LDL low density
lipoprotein, HDL how density lipoprotein, eGFR estimated glomerular filtration rate, RAS renin angiotensin system. Variables are expressed as the means ± SD or
median (25th,75th percentiles).
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creased to approximately 15 ng/mL; however, the UACR
level increased with decreasing serum 25(OH)D to ap-
proximately less than 15 ng/mL of serum 25(OH)D level.
Based on the findings, we investigated the non-linear re-
lationship between serum 25(OH)D and UACR levels,
and we estimated the threshold level of serum 25(OH)D
less than which UACR levels started to increase. To esti-
mate the threshold, we used GAM, and we made adjust-
ments for relevant covariates, including age, sex, season,
BMI, hemoglobin, eGFR, hypertension, diabetes, use of
vitamin D supplements and RAS blockers, serum albumin,
calcium, phosphorus, high-density lipoprotein (HDL) cho-
lesterol, triglycerides, and high-sensitivity-C-reactive
protein (hs-CRP), in a stepwise manner. In each model,
we used the AIC to assess model fit, and we finally
selected the best-adapted model for estimating the
threshold. Figure 3 shows the unadjusted, age-, sex-,
and season-adjusted, and multivariate-adjusted GAMplots used to identify the threshold level of 25(OH)D
that predicted changes in UACR levels. In the best
adapted model, adjusted for potential confounding fac-
tors, 8.0 ng/mL of serum 25(OH)D had the lowest AIC
value: the difference from the mean UACR began to
increase as the serum 25(OH)D level decreased to less
than the threshold level of 8.0 ng/mL.
Risk of high-normal UAE according to the serum 25(OH)D
levels
We investigated whether serum 25(OH)D levels were sig-
nificantly associated with the prevalence of high-normal
UAE, using a logistic regression model. A stepwise in-
crease in the prevalence of high-normal UAE was ob-
served with decreasing serum 25(OH)D levels, which
were indicated by quartiles, percentiles, and clinical
categories (Figure 4). However, we observed a signifi-
cant increase in high-normal UAE in only the lowest
category of serum 25(OH)D, which indicated very low
Figure 2 Scatter plot with the lowess regression curve between
serum 25-hydroxyvitamin D and urinary albumin-creatinine
ratio. A single unbroken line represents the mean value of the
urinary albumin-creatinine ratio.
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http://www.biomedcentral.com/1471-2369/15/97vitamin D levels. Adjusting for multiple covariates, in-
cluding age, sex, season, BMI, hemoglobin, eGFR,
hypertension, diabetes, use of vitamin D supplements and
RAS blockers, serum albumin, calcium, phosphorus, HDL
cholesterol, triglycerides, and hs-CRP, all of the lowest cat-
egories of serum 25(OH)D levels, by quartile, percentile,
and clinical category, were significantly associated with the
risk of high-normal UAE. The OR of the lowest quartileFigure 3 25-hydroxyvitamin D threshold values suggested by genera
intervals for value of the smoothed urine albumin creatinine ratio *Adjusted fo
filtration rate, hypertension, diabetes, use of vitamin D supplements, and/or re
high-density lipoprotein-cholesterol, triglyceride, and high sensitivity-C-reactivover the highest quartile was 1.20 (95% CI, 1.04-1.39),
the OR of the 1.0-4.9% over the 50.0-100.0% was 1.56
(95% CI, 1.25-1.93), and the OR of subjects with vitamin
D deficiency over those with vitamin D sufficiency was
1.28 (95% CI, 1.08-1.52). Stratified analyses according
to the presence or absence of diabetes showed similar
patterns. In the subjects with diabetes, multivariate-
adjusted odds of high-normal UAE were significantly
higher in the lowest serum 25(OH)D quartile and in
vitamin D deficiency defined by the clinical category.
The risk of high-normal UAE in non-diabetic subjects
with vitamin D deficiency was also significantly higher
than that in non-diabetic subjects with vitamin D suffi-
ciency (Additional file 1: Figure S1).
Figure 5 presents the predicted probability of high-
normal UAE based on serum 25(OH)D levels. After full
adjustments for age, sex, season, BMI, hemoglobin, eGFR,
hypertension, diabetes, use of vitamin D supplements and
RAS blockers, serum albumin, calcium, phosphorus, HDL
cholesterol, triglycerides, and hs-CRP, the predicted prob-
ability of high-normal UAE increased non-linearly with
decreasing serum 25(OH)D levels, particularly at approxi-
mately the threshold levels of serum 25(OH)D.
Discussion
In the present study, conducted in a large number of
health-screening subjects, we demonstrated a non-linear
relationship between serum 25(OH)D and UACR levels
in normoalbuminuric subjects, and we identified the
threshold level of serum 25(OH)D that predicted an
increase in UAE, independent of confounding variables.
Because the serum 25(OH)D threshold was lower than
the generally accepted lower limit of the normal range,lized additive model plots. The dashed line indicates 95% confidential
r age, sex, season, body mass index, hemoglobin, estimated glomerular
nin-angiotensin system blocker, serum albumin, calcium, phosphorus,
e protein. UACR, urinary albumin-creatinine ratio.
Figure 4 Odds ratios for high-normal urinary albumin excretion (UACR 10–29 mg/g) as a function of serum 25-hydroxyvitamin D levels
by quartile categories (top), percentile categories (middle), and clinical categories (bottom). Black round dots represent odds ratios,
and error bars represent the 95% CIs. *Adjusted for age, sex, season, body mass index, hemoglobin, estimated glomerular filtration rate,
hypertension, diabetes, use of vitamin D supplements, and/or renin-angiotensin system blocker, serum albumin, calcium, phosphorus, high-density
lipoprotein-cholesterol, triglyceride, and high sensitivity-C-reactive protein. UACR, urinary albumin-creatinine ratio.
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ciency could cause an increase in UAE. Additionally, we
demonstrated that the risk of high-normal UAE (UACR
10–29 mg/g) increased as the serum 25(OH)D level de-
creased; however, the trend was not linear. Thus, the
present study raises the important issue that vitamin D
could be a potential therapeutic option for the manage-
ment or prevention of increases in UAE in normoalbu-
minuric subjects with severe vitamin D deficiency.
Increases in UAE, even within the normoalbuminuric
range, constitute a well-known risk factor for adverseFigure 5 Predicted prevalence curve for high-normal urinary albumin
to serum 25-hydroxyvitamin D levels. Dashed lines represent 95% CIs
estimated glomerular filtration rate, hypertension, diabetes, use of vitam
albumin, calcium, phosphorus, high-density lipoprotein-cholesterol, trig
albumin-creatinine ratio.cardiovascular outcomes in high-risk individuals [27,28].
More recently, high-normal UAE has become a critical
public health issue because high-normal UAE has been
associated with the risk of cardiovascular disease and
all-cause mortality in the general population [4,5,29].
Additionally, because large-scale, population-based studies
have documented a high prevalence of high-normal UAE,
ranging from 13% to 23% [30-33], its public health aspects
require greater attention. However, despite its significance
for public health, there have been few studies investigating
its causative or potentially modifiable risk factors, otherexcretion in subjects with UACR < 30 mg/g (n = 14,594) according
. *Adjusted for age, sex, season, body mass index, hemoglobin,
in D supplements, and/or renin-angiotensin system blocker, serum
lyceride, and high sensitivity-C-reactive protein. UACR, urinary
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obesity. Given that low-grade albuminuria reflects gen-
eralized vascular dysfunction via impaired endothelial
function, activation of the RAS, and chronic low-grade
inflammation [34-37]. conditions relevant to the devel-
opment of these pathogenic processes could constitute
potential risk factors for high-normal UAE. In this
respect, vitamin D deficiency is a likely mechanism for
the increase in UAE, as it has been shown to play a cru-
cial role in vascular dysfunction. Recent studies have
suggested that flow-mediated dilatation, which is a
standard tool for measuring endothelial function, was
significantly impaired in subjects with vitamin D defi-
ciency [38,39]. Vitamin D deficiency also adversely
affected vascular function by inappropriate activation of
the RAS [40], and chronic inflammation [41]. These
processes might, in turn, increase UAE, even in the ab-
sence of evident kidney disease. The data presented
show that severe vitamin D deficiency was significantly,
but non-linearly, correlated with high-normal UAE,
even after adjustment for traditional risk factors for
albuminuria. Similar to our results, a previous study
found that low serum 25(OH)D levels were associated
with an increased prevalence of albuminuria in a gen-
eral population [14]. However, in that study, microalbu-
minuria (defined as UACR of 17–249 mg/g for men and
25–354 mg/g for women), but not high-normal UAE,
was considered to be a dependent variable, so the refer-
ence group included a large number of subjects with
high-normal UAE, which is a proven risk factor for
adverse outcomes.
Recently, mounting evidence has suggested that the in-
verse associations between serum 25(OH)D levels and
risk factors in cardiovascular outcomes might be non-
linear, involving a threshold effect [15,18,19]. Given the
close pathophysiological association between albumin-
uria and cardiovascular disease, serum 25(OH)D levels
could also have a threshold effect on levels of UAE. The
present results of GAM, which is a non-parametric
regression method used to address non-linearity between
variables [26], are consistent with the hypothesis that the
association between serum 25(OH)D and UACR levels
is non-linear. However, the threshold serum 25(OH)D
concentration in this study (8 ng/mL) was much lower
than that reported in previous studies that explored the
associations between serum 25(OH)D levels and risk fac-
tors for cardiovascular disease. Previous studies have
demonstrated that the risk for cardiovascular disease
began to increase significantly at less than 15 to 30 ng/mL
of serum 25(OH)D [15,18,19], which is relevant to the
current definition of vitamin D deficiency. Considering
the high prevalence of vitamin D deficiency in the gen-
eral population, a substantial number of subjects would
be expected to be at vitamin D deficiency-related riskfor cardiovascular disease. However, most randomized,
controlled trials with vitamin D supplementation have
failed to demonstrate improved vascular function or
cardiovascular outcomes [42-44], suggesting that low
vitamin D levels simply reflect health status, rather than
directly causing disease. An alternate explanation for
the discrepancy is that vitamin D plays an independent
role in the development of cardiovascular disease or vas-
cular dysfunction, when its levels decrease to less than
very low levels. This hypothesis was supported by a recent
large-scale, population-based study, which demonstrated
that only a very low vitamin D level (<5th percentile of
serum 25(OH)D) significantly increased the risk of fatal
ischemic heart disease after adjustment for traditional
cardiovascular risk factors [39]. In accordance with the
previous study, the present study also demonstrated
that the 25(OH)D threshold levels decreased after
adjustment for the traditional cardiovascular risk factors
in GAM analysis. Additionally, only the lowest category
of serum 25(OH)D was correlated with elevated odds of
high-normal UAE after multivariate adjustment. These
findings suggest that vitamin D levels related to the
pathogenesis of low-grade albuminuria might be lower
than the lower limit of the normal range of vitamin D.
This outcome could be one of the possible indirect
explanations for the negative results of randomized,
controlled trials regarding the effects of vitamin D sup-
plementation on vascular function, as low-grade albu-
minuria could reflect generalized vascular dysfunction.
There were several limitations to the present study.
First, UAE was measured from only a single random
urine sample. Individual variability in UACR levels could
have caused measurement error for UAE. Second, there
was a lack of information on vitamin D dietary intake
and outdoor physical activities, which exert effects on
vitamin D status. Third, the current investigation was
cross-sectionally designed. We could not establish a causa-
tive or temporal relationship between vitamin D levels and
UAE. Thus, we could not demonstrate whether use of
vitamin D could reduce urinary albumin loss in a healthy
population with very low degrees of UAE. Finally, the
laboratory test methods were not consistent among the
institutions. Thus, to combine laboratory test results
from different institutions, a normalization process,
which transformed different distributions into identical
distributions in statistical properties, was indispensable.
We used quantile normalization, which is the most
widely used normalization method for genetic studies
[22]. This method makes the distribution of different
datasets as similar as possible while conserving the
meaning of original values. To consider the reference
range of laboratory tests, we partitioned each datasets into
three groups (upper range, within range and below range),
and each of them were independently normalized. By
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serving the clinical meaning and considering the refer-
ence range. Because this method does not assume any
parametric distributions, the method can be applied to
any laboratory test results with various distributions.
Conclusions
Severe vitamin D deficiency was independently associ-
ated with an increased prevalence of high-normal UAE,
which has tended to be overlooked. Based on the clinical
significance of low-grade albuminuria as a predictor of
vascular dysfunction and cardiovascular mortality [4,29],
the clinical implications of severe vitamin D deficiency in
public health as a modifiable risk factor for low-degree
albuminuria might be substantial. We confirmed a non-
linear relationship between vitamin D levels and UAE,
as well as the threshold (8 ng/mL) less than which vita-
min D levels began to be associated with an increase in
UAE. Additional clinical studies are warranted to validate
our study and to evaluate whether vitamin D therapy
could reduce urinary albumin loss in normoalbuminuric
individuals.
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